OrbiMed Overview

  • Investor Type
  • PE/​Buyout
  • Status
  • Active
  • Professionals
  • 57
Professionals
  • Investments
  • 757
  • Portfolio
  • 228
  • Exits
  • 359
Exits

OrbiMed General Information

Description

Founded in 1989, OrbiMed is a private equity firm based in New York, New York. The firm seeks to invest in the biopharmaceutical, life sciences, digital health, healthcare services, medical devices, and diagnostic sectors. The firm also manages long and short event-driven strategy hedge funds and closed-end investment trusts.

Contact Information

Website
www.orbimed.com
Year Founded
1989
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Other Investor Types
Asset Manager
Growth/Expansion
Hedge Fund
Venture Capital
Primary Office
  • 601 Lexington Avenue (at 53rd Street)
  • 54th Floor
  • New York, NY 10022-4629
  • United States
+1 (212) 000-0000

OrbiMed Investments & Acquisitions (757)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000 01-Mar-2022 00000 00000 0000 Medical Records Systems Generating Revenue
0000000 0000000000 16-Feb-2022 00000 00000 0000 Biotechnology Clinical Trials - Phase 1 0000 000000 00.0
00000 00000000 000 16-Feb-2022 00000 00000 00000 Discovery Tools (Healthcare) Clinical Trials - Phase 1 00000 000000 00
00000000 000000000 14-Feb-2022 00000 00000 00000 Drug Discovery Clinical Trials - General
Congruence Therapeutics 08-Feb-2022 Seed Round 0000 Drug Discovery Startup 00000 000000 00
You’re viewing 5 of 757 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OrbiMed Exits (359)

Company Name Exit Date Exit Type Exit Size
0000000 14-Jan-2022 0000000 000000 00000
00000 00000 07-Jan-2022 000 0000
000000 00000000000 31-Dec-2021 000 00 00000000
00000 000000000000 31-Dec-2021 000 00 00000000
Bioheart Biotechnology 23-Dec-2021 IPO 000.00
You’re viewing 5 of 359 exits. Get the full list »

OrbiMed Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore OrbiMed‘s full profile, request access.

Request a free trial

OrbiMed Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

OrbiMed Team (129)

Name Title Deals Funds Boards Office
Trey Block Chief Financial Officer New York, NY
Daniel Rhee Chief Technology Officer New York, NY
David Wang Ph.D Partner & Senior Managing Director 00 0 0 Shanghai, China
Sunny Sharma Partner & Senior Managing Director, Asia 00 0 0 Mumbai, India
Steven Wang Ph.D Partner & Senior Managing Director, Asia 0 New York, NY
You’re viewing 5 of 129 team members. Get the full list »